PIAZZA, ROCCO GIOVANNI

PIAZZA, ROCCO GIOVANNI  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 152 (tempo di esecuzione: 0.022 secondi).
Titolo Tipologia Data di pubblicazione Autori File
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses 01 - Articolo su rivista 2000 PIAZZA, ROCCO GIOVANNI +
Il connettivo (collageno e proteoglicani) 03 - Contributo in libro 2002 PIAZZA, ROCCO GIOVANNI +
Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels 01 - Articolo su rivista 2003 GAMBACORTI PASSERINI, CARLOPIAZZA, ROCCO GIOVANNI +
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 02 - Intervento a convegno 2003 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERACAZZANIGA, GIOVANNI ITALOBIONDI, ANDREAPOGLIANI, ENRICO MARIACORNEO, GIANMARCOGAMBACORTI PASSERINI, CARLO +
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 01 - Articolo su rivista 2003 PIAZZA, ROCCO GIOVANNI +
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias 01 - Articolo su rivista 2003 GAMBACORTI PASSERINI, CARLOPIAZZA, ROCCO GIOVANNIROSTAGNO, ROBERTA +
Development of c-Kit-expressing Small-Cell lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment 01 - Articolo su rivista 2004 GAMBACORTI PASSERINI, CARLOPIAZZA, ROCCO GIOVANNIPOGLIANI, ENRICO MARIA +
SNP MINING BY NANOGEN DEVICE: A SENSITIVE TOOL FOR THE IDENTIFICATION OF BCR/ABL MUTATIONS IN PH+ PATIENTS 02 - Intervento a convegno 2004 CORRADI, BARBARAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLOBIONDI, ANDREACAZZANIGA, GIOVANNI ITALO +
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 01 - Articolo su rivista 2004 Cazzaniga, GPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLOBIONDI, ANDREA +
ABL INHIBITOR BMS354825 BINDING MODE IN ABELSON KINASE REVEALED BY MOLECULAR DOCKING STUDIES 02 - Intervento a convegno 2005 GAMBACORTI PASSERINI, CARLOPIAZZA, ROCCO GIOVANNI +
Response to 'D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients' by Leguay et al 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNI +
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
NPM/ALK co-localizes with, and phosphorylates PSF and other RNA-binding proteins 02 - Intervento a convegno 2005 PIAZZA, ROCCO GIOVANNIPUTTINI, MIRIAMGAMBACORTI PASSERINI, CARLO +
Autoimmune hepatitis presenting as imatinib toxicity: description of a case and of therapeutic alternatives 02 - Intervento a convegno 2005 PIAZZA, ROCCO GIOVANNIPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
SIGNIFICANT REDUCTION IN FASTING BLOOD GLUCOSE IN NONDIABETIC PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB MESYLATE 02 - Intervento a convegno 2005 PIAZZA, ROCCO GIOVANNIPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 02 - Intervento a convegno 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAFRANCESCHINO, ANNAGAMBACORTI PASSERINI, CARLO +
Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease 01 - Articolo su rivista 2006 FRANCESCHINO, ANNAPIAZZA, ROCCO GIOVANNIPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 01 - Articolo su rivista 2006 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +